A study on animal models has shown that the protective effect of DHEA on high-fat-induced hepatic glycolipid metabolic disorder and insulin resistance might be achieved through the activation of the AMPK-PGC-1α-NRF-1 and IRS1-AKT-GLUT2 signaling pathways [62]. The gene discussed is IRS1; the disease is Insulin resistance.